TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competitionContract termination notice
Published 5 Dec 2025, 16:13 GMT

Official UK procurement notice

Blood Group Genotyping for Sickle Cell and Thalassaemia

Official notice

Authority: NHS England (Central government)

Direct award
Sectors: Health & Social Care (85) Delivery: Delivery location not published
Awarded value£140,671published award · exc. VAT
Awarded 15 May 2025no call for competition
Awarded to NHSBT

What is being bought

Published requirement description

Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to commencing 25 June 2025 until 31 March 2026.

The lotProcurement structure

single lot · no lot value published
Lot #1Awarded
85100000 Health services

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
5 Dec 2025, 16:13 GMT
Last source update
10 Jun 2026, 11:18 BST
Authority reference
C369873
FTS notice number
2026/S 000-054644
Latest notice
Contract termination notice (UK11)
Delivery area
Not published
Official registry OCID
ocds-h6vhtk-05f01d Find a Tender
Why no open competition
Single Suppliers Intellectual Property Exclusive Rights
Published justification

PA23 Sch.5 Single supplier - technical reasons

How it was run

Official notice
Submission deadline
—

Timeline

16 Dec 2025 → 10 Jun 2026 · 2 dates
  1. Standstill ends315 days ago
    16 Dec 2025, 23:59 GMT
  2. Notice published140 days ago
    10 Jun 2026, 11:18 BST

Notice history

5 events · 4 releases on Find a Tender · since 5 Dec 2025
  1. Transparency notice published
    5 Dec 2025, 16:13 GMT
    UK5
  2. Contract award notice published
    5 Dec 2025, 16:50 GMT
    UK6
  3. Contract signature expected
    18 Dec 2025, 23:59 GMT
    scheduled
  4. Contract details notice published
    10 Jun 2026, 10:25 BST
    UK7
  5. Contract termination notice published
    10 Jun 2026, 11:18 BST
    UK11
Routine re-releases (4)
  • 2025-12: 1 release · 5 Dec 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £140,6711 award exc. VAT
Contracts signed 1latest 10 Jun 2026
Awarded toValueDateStatus
NHSBT19 Dec 2025 – 31 Mar 2026£140,67115 May 2025Awarded

Contracts

  • Blood Group Genotyping for Sickle Cell and Thalassaemia · NHSBT

    Signed
    10 Jun 2026
    Value
    £140,671
    Period
    10 Jun 2026 – 11 Jun 2026
    Status
    terminated, This contract termination is being published to advise of the end of this contract. The delay in publishing this notice is due to administrative and operational circumstances.
    Final value
    £140,671
    Termination
    contractCompleted

    No agreed KPIs: Not required

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact email

Bidders & participating suppliers

1 commercial party on the notice
  • NHSBTAwarded supplierGB-NHS: T1460 500 North Bristol Park, Filton, Bristol, South West, BS34 7QHContact email, phone

Official documents & specifications (4)

Official links; attachments are not copied

Notices published for this procedure